Patents Assigned to SCANDINAVIAN BIOPHARMA HOLDING AB, C/O ETVAX AB
  • Vaccine for protection against ETEC-induced diarrhea comprising dmLT
    Patent number: 11918636
    Abstract: An oral vaccine for immunization against ETEC-induced diarrhea, comprising inactivated Escherichia coli cells expressing an ETEC colonization factor antigen and dmLT protein adjuvant, wherein the vaccine preferably comprises less than 1013 cells per unit dose.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: March 5, 2024
    Assignee: SCANDINAVIAN BIOPHARMA HOLDING AB, C/O ETVAX AB
    Inventors: Ann-Mari Svennerholm, Joshua Tobias, Nils Carlin, Jan Holmgren